The Bruder Consulting and Venture Group (www.bruderconsulting.com) provides services to start-up through multi-national conglomerate medical device, regenerative medicine and biotechnology companies, investment banks, venture partners and private equity firms. The company’s dedicated team of executive Engagement Partners offers clients a diversified expertise in technology, product and market development, clinical and regulatory affairs, reimbursement and health economics, and commercialization strategy, including financial and/or strategic partnering. Agreements with exceptional “Affiliate Firms” that provide complimentary services to the Group, such as laboratory and animal studies for regulatory approval, global clinical trial execution, and intellectual property analysis and valuation, along with a set of world renown "Special Advisors" from academia, distinguish the Group from more traditional boutique consulting firms. Clients include companies in the United States, Europe, Israel, Australia, and Japan.